IRIS
ORIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.999
EU - Europa 11.361
AS - Asia 6.116
SA - Sud America 903
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 64
OC - Oceania 25
Totale 41.546
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.889
RU - Federazione Russa 3.468
UA - Ucraina 2.805
VN - Vietnam 1.838
CN - Cina 1.813
SG - Singapore 1.774
GB - Regno Unito 1.202
SE - Svezia 1.114
DE - Germania 1.027
BR - Brasile 708
FR - Francia 598
IT - Italia 438
FI - Finlandia 342
KR - Corea 128
PL - Polonia 120
IN - India 101
HK - Hong Kong 80
EU - Europa 62
IQ - Iraq 59
BD - Bangladesh 58
AR - Argentina 57
CA - Canada 51
NL - Olanda 42
TR - Turchia 35
VE - Venezuela 35
JP - Giappone 34
CO - Colombia 31
SA - Arabia Saudita 29
BE - Belgio 28
MX - Messico 27
PK - Pakistan 27
EC - Ecuador 26
AT - Austria 24
LV - Lettonia 23
UZ - Uzbekistan 22
ZA - Sudafrica 21
AU - Australia 19
ES - Italia 19
IE - Irlanda 19
PH - Filippine 18
ID - Indonesia 16
MA - Marocco 15
TN - Tunisia 12
CL - Cile 11
DK - Danimarca 10
PE - Perù 10
PT - Portogallo 10
PY - Paraguay 10
BG - Bulgaria 8
BO - Bolivia 8
JO - Giordania 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
HU - Ungheria 7
IL - Israele 7
KE - Kenya 7
AE - Emirati Arabi Uniti 6
BY - Bielorussia 6
EG - Egitto 6
HR - Croazia 6
MY - Malesia 6
OM - Oman 6
PA - Panama 6
RS - Serbia 6
AL - Albania 5
BH - Bahrain 5
JM - Giamaica 5
LT - Lituania 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
CR - Costa Rica 4
KG - Kirghizistan 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
KW - Kuwait 3
LU - Lussemburgo 3
MM - Myanmar 3
NO - Norvegia 3
RO - Romania 3
TW - Taiwan 3
AO - Angola 2
BN - Brunei Darussalam 2
CY - Cipro 2
DZ - Algeria 2
EE - Estonia 2
GD - Grenada 2
IM - Isola di Man 2
IR - Iran 2
LB - Libano 2
ME - Montenegro 2
NG - Nigeria 2
NP - Nepal 2
SR - Suriname 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
BB - Barbados 1
BZ - Belize 1
Totale 41.515
Salva come PNG Salva come JPEG
Città #
Fairfield 2.739
Woodbridge 2.587
Houston 1.973
Ashburn 1.660
Dong Ket 1.474
Ann Arbor 1.448
Chandler 1.364
Wilmington 1.312
Seattle 1.085
Dallas 1.002
Cambridge 933
San Jose 894
Dearborn 890
Jacksonville 776
Singapore 666
Southend 630
Nyköping 614
Boardman 475
Moscow 428
Beijing 377
Lawrence 258
Princeton 258
The Dalles 208
Ogden 178
Düsseldorf 137
Shanghai 127
Ho Chi Minh City 124
Des Moines 115
Kraków 108
Los Angeles 106
Hanoi 92
Yubileyny 90
San Diego 88
Helsinki 82
Bremen 75
Hong Kong 69
Grafing 66
Nanjing 62
New York 60
São Paulo 58
Jinan 55
London 53
Hefei 40
Santa Clara 38
Chicago 37
Frankfurt am Main 33
Tokyo 32
Edinburgh 28
Norwalk 28
Brussels 27
Shenyang 27
Amsterdam 26
Kunming 24
Munich 24
San Mateo 24
Baghdad 23
Da Nang 23
Riga 23
Guangzhou 22
Rome 22
Napoli 21
Nanchang 20
Council Bluffs 19
Rio de Janeiro 19
Tashkent 19
Auburn Hills 18
Belo Horizonte 18
Chennai 17
Hanover 17
Phoenix 17
Zhengzhou 17
Mirabella Eclano 16
Taiyuan 16
Boston 15
Curitiba 14
Dublin 14
Hangzhou 14
Kilburn 14
Montreal 14
Naples 14
Vienna 14
Atlanta 13
Brooklyn 13
Hebei 13
Riyadh 13
Tianjin 13
Changsha 12
Columbus 12
Falls Church 12
Saint Petersburg 12
Brasília 11
Caracas 11
Hounslow 11
Johannesburg 11
Porto Alegre 11
San Francisco 11
Stockholm 11
Acton 10
Campinas 10
Fuzhou 10
Totale 26.864
Salva come PNG Salva come JPEG
Nome #
Il microinfusore: quali indicazioni e quando iniziare 468
Sussidio didattico per gli studenti di igiene generale e applicata per il corso di laurea in scienze del servizio sociale 331
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 298
Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity 268
The good and bad effects of statins on insulin sensitivity and secretion 250
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 246
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. 242
A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination. 237
Secrezioni ormonali ectopiche 237
Effects of physical exercise on the female reproductive system. 236
Cardiopulmonary impairment in young women with polycystic ovary syndrome. 236
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies. 230
Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance 227
Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside. 225
A stable prostatic bioluminescent cell line to investigate androgen and antiandrogen effects. 222
Cardiological aspects of growth hormone and insulin-like growth factor-I. 220
The Risk of a Persistent Glucose Metabolism Impairment After Gestational Diabetes Mellitus Is Increased in Patients With Polycystic Ovary Syndrome 220
Endocrine secretions under abnormal light-dark cycles and in the blind. 216
Failure of long-term therapy with sodium valproate in Cushing's disease. 212
Vitamin D and thyroid disease: to D or not to D? 212
Adiponectin levels in women with polycystic ovary syndrome 212
Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial. 208
Adrenal mass: insight into pathogenesis and a common link with insulin resistance. 208
THE IMPACT OF PROBAND GLUCOSE TOLERANCE STATUS ON BODY MASS INDEX (BMI) AND ADIPOSITY IN ADOLESCENT GIRLS AT HIGH RISK FOR POLYCYSTIC OVARY SYNDROME (PCOS) 207
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 207
Height, weight, height velocity of primary school population sample in Campania region. 206
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 206
Effects of neridronate treatment in elderly women with osteoporosis 203
Ovulation induction in polycystic ovary syndrome 203
Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood and quality of life 202
Bisphenol A in Polycystic Ovary Syndrome and its Association with Liver-Spleen Axis. 201
Lifestyle changes in the management of adulthood and childhood obesity. 201
Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens. 200
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 200
Report on the Third Annual Meeting of the Androgen Excess Society, San Diego, California, June 3, 2005 199
Liver-spleen axis, Insulin-like Growth Factor-(IGF)-I axis and fat mass in overweight/obese females 199
Effect of growth hormone on cardiac function. 198
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. 198
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes. 197
Are serum adiponectin levels really reduced in obese women with polycystic ovary syndrome? 197
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine. 196
The increase of leukocytes as a new putative marker of low- grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome 196
Hypothalamic-pituitary-gonadal axis function after successful kidney transplantation in men and women 196
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept. 196
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women. 195
Adrenocortical tumors and insulin resistance. What is the first step? 195
Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review 194
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 194
Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response 194
Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. 193
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 193
Insulin resistance in postmenopausal women with metabolic syndrome and the measurements of adiponectin, leptin, resistin, and ghrelin 192
Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome. 192
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome 192
Growth hormone secretion after baclofen administration in different phases of menstrual cycle in healthy women 191
Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. 191
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 191
Is the ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome? 190
Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial. 190
Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS 190
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. 190
How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology. 190
Does raloxifene inhibit the growth of uterine fibroids? 189
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 189
Auditory brainstem responses in thyroid diseases before and after therapy. 189
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors 189
Growth hormone status in morbidly obese subjects and correlation with body composition 188
Effect of estrogen replacement plus low-dose alendronate treatment on bone density in surgically postmenopausal women with osteoporosis. 188
Thyroid function and morphology after a successful kidney transplantation 188
Endothelial dysfunction in PCOS: role of obesity and adipose hormones. 188
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 188
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome 188
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome 187
Terapia di associazione con insulina ed analoghi del GLP-1 187
Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials 186
Current evidence on vitamin D deficiency and kidney transplant: What’s new? 186
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 185
Role of dehydroepiandrosterone sulfate levels on body composition after laparoscopic adjustable gastric banding in pre-menopausal morbidly obese women 184
Cardiovascular risk of women with polycystic ovary syndrome 184
Efficacy of laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: relationships with chronological and ovarian age 183
Circulating ghrelin concentrations in the polycystic ovary syndrome 183
Prevalence of polycystic ovary morphology in a region of South Italy. 183
Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. 182
GH and IGF-I deficiency are associated with reduced loss of fat mass after laparoscopic-adjustable silicone gastric banding. 182
Antisperm antibodies in cryptorchidism before and after surgery. 182
Evidence for altered adipocyte function in polycystic ovary syndrome. 181
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome 181
Clinical use of the perifollicular vascularity assessment in IVF cycles: a pilot study 181
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 180
Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis 180
Lymphocyte subset pattern in acromegaly. 180
Growth hormone treatment prevents loss of lean mass after bariatric surgery in morbidly obese patients: results of a pilot, open, prospective, randomized, controlled study 179
Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. 178
Anti-proliferative and pro-apoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women 178
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 178
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome:A Prospective Parallel Randomized Double-Blind Placebo-Controlled Trial 177
Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome 176
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome (PCOS) 175
Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women 175
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study. 174
Totale 20.277
Salva come PNG Salva come JPEG
Categoria #
all - tutte 161.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 161.596
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.929 0 0 0 0 0 0 0 0 0 0 129 1.800
2021/20222.163 139 314 34 771 76 45 253 199 141 116 69 6
2022/20234.290 523 136 215 458 498 796 115 566 571 120 223 69
2023/20241.231 134 71 77 54 54 34 25 316 268 56 12 130
2024/20255.948 86 505 15 133 86 499 1.693 2.000 322 199 205 205
2025/20266.166 491 820 523 413 413 163 988 645 948 710 52 0
Totale 41.974